The College of Medicine has a President and two Vice Presidents with an extensive knowledge of healthcare in the UK.
President
Dr Harry Brünjes
Dr Harry Brünjes initially graduated from London University and then qualified in medicine at Guy’s Hospital. In 1995 Harry started the Premier Medical Group alongside his Harley Street practice. In 2005, after ten years as CEO, he became Chair of The Premier Medical Group. A subsidiary RTA Limited was sold to BUPA in 2005. In 2010 PMG was acquired by Capita. In 2016 Harry re-acquired PMG and subsequent acquisitions are WARP Technology, Medicals Direct, PhysioLink, MindLink, MedChi and rebranded as Kuro Health in 2021. Other appointments have included Chair of the Personal Injury Forum at BUPA, Chair of Newmans Clinics and non-executive at The Good Care Group and Equity Red Star, Lloyd’s Syndicate.
Previously Harry was Governor of Bedford Modern School, Chair of Mowden School, Chair of Lancing Prep, Governor of Valderrama Golf Club and The Expert Witness Institute. In 2007 Harry was President of the Sussex Medico-Chirurgical Society. In 2010 Harry was elected Vice-President of the College of Medicine. Harry is a Fellow of the Royal Society of Medicine, a Fellow of the Royal College of Physicians Edinburgh, a Fellow of the Woodard Corporation and a Council member of Southwark Cathedral Development Trust. Harry was Chair of Lancing College between 2009 – 2019. In 2021 Harry was appointed Chair of the Foundation Council of Lancing College. Harry is Chair of the English National Opera and The London Coliseum, and is also Chair of Capital Theatres, Edinburgh. Harry is a Trustee of the National Academy of Social Prescribing.
In 2025, he was awarded a CBE in the King’s New Year Honours list.
Vice Presidents
Professor Sir Muir Gray CBE MD
Sir Muir Gray was the first person to hold the post of Chief Knowledge Officer of the NHS (England), also serving as the co-Director of the Department of Health’s Quality Innovation Productivity and Prevention (QIPP) Right Care Programme. Together with Sir Iain Chalmers, Muir was instrumental in establishing the Cochrane Collaboration. He is an internationally renowned authority on healthcare systems.
He is currently Consultant in Public Health, Oxford University Hospitals NHS Trust, Visiting Professor Oxford University for Knowledge Management in the Nuffield Department of Surgical Sciences and for Value Based Healthcare in the Nuffield Department of Primary Care Health Sciences.
Sir Cyril Chantler GBE, MD, FMed Sci, FRCP, FRCPH
Honorary Fellow and Emeritus Chairman of UCLPartners Academic Health Science Partnership. Trustee of Cicely Saunders International and a member of the advisory board of Medefer.
Cyril Chantler was Dean of the Guy’s, King’s College and St Thomas’ Hospitals’ Medical and Dental School, where he was the Children Nationwide Medical Research Fund Professor of Paediatric Nephrology until his retirement in 2000. He was a consultant to Guy’s Hospital (1972 – 2000). Previously, he was Principal of the United Medical and Dental School of Guy’s and St Thomas’s Hospitals (1992 – 1998) and General Manager of Guy’s Hospital (1985-1988). He was Chairman of Great Ormond Street Hospital for Children (2001- 2008), of the Clinical Advisory Group for NHS London 2007/2008 and of the Beit Memorial Fellowships for Medical Research (2003-2009). From 2004 until 2010 he was Chairman of the Kings Fund, London. He was a member of the editorial board of the Journal of the American Medical Association from 2002 to 2011. He was the Chairman of UCLPartners Academic Health Science Partnership from its inception in 2009 until 2014. He was non-executive Chairman of the Quality and Clinical Risk Committee of NHS England from 2013 -2014. Non-executive director of the fostering agency By the Bridge 2006-2015. In 2014 he carried out a review for the government on Standardised Packaging of tobacco products. Non Executive Director Private Health Information Network 2015-2024. Vice Chairman Stakeholder Council National Maternity Review 2015- 2017, Vice Chairman Independent Review of Medicines and Medical Devices 2018-2020.